ATE179422T1 - Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel - Google Patents

Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel

Info

Publication number
ATE179422T1
ATE179422T1 AT94927771T AT94927771T ATE179422T1 AT E179422 T1 ATE179422 T1 AT E179422T1 AT 94927771 T AT94927771 T AT 94927771T AT 94927771 T AT94927771 T AT 94927771T AT E179422 T1 ATE179422 T1 AT E179422T1
Authority
AT
Austria
Prior art keywords
pct
derivatives
chinolonylcarboxamidocephalosporine
products containing
containing same
Prior art date
Application number
AT94927771T
Other languages
English (en)
Inventor
Constantino Miguel Angel Corpi
Original Assignee
Aranda Lab Sa De Cv
Arrieta Munguia Judith Marcia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aranda Lab Sa De Cv, Arrieta Munguia Judith Marcia filed Critical Aranda Lab Sa De Cv
Application granted granted Critical
Publication of ATE179422T1 publication Critical patent/ATE179422T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
AT94927771T 1994-02-25 1994-10-07 Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel ATE179422T1 (de)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
MX9401427 1994-02-25
MX9403331 1994-05-06
MX9403394 1994-05-09
MX9406681 1994-09-01
MX9406682 1994-09-01
MX9406680 1994-09-01
MX9407838 1994-09-05

Publications (1)

Publication Number Publication Date
ATE179422T1 true ATE179422T1 (de) 1999-05-15

Family

ID=27567169

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94927771T ATE179422T1 (de) 1994-02-25 1994-10-07 Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel

Country Status (8)

Country Link
US (1) US5728691A (de)
EP (1) EP0746561B1 (de)
AT (1) ATE179422T1 (de)
AU (1) AU7706394A (de)
CO (1) CO4340690A1 (de)
DE (1) DE69418218T2 (de)
ES (1) ES2132430T3 (de)
WO (1) WO1995023153A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996034007A1 (es) * 1995-04-27 1996-10-31 Laboratorios Aranda, S.A. De C.V. Derivados de quinolonilcarboxieritromicina y composiciones farmaceuticas que los contienen
LT2502911T (lt) 2004-06-24 2017-09-11 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
US7573973B2 (en) * 2005-05-17 2009-08-11 General Electric Company Methods and systems to facilitate reducing cone beam artifacts in images
CA2634113A1 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of abc transporters
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
SI2408750T1 (sl) 2009-03-20 2015-11-30 Vertex Pharmaceuticals Incorporated Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
EP2819670A1 (de) 2012-02-27 2015-01-07 Vertex Pharmaceuticals Incorporated Pharmazeutische zusammensetzung und verabreichung davon
KR20170063954A (ko) 2014-10-07 2017-06-08 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468394A (en) * 1981-04-02 1984-08-28 Eisai Co., Ltd. Cephalosporin compounds
US4404201A (en) * 1981-11-13 1983-09-13 Warner-Lambert Company Cephalosporins
ZA874696B (en) * 1986-07-03 1988-01-04 F. Hoffmann-La Roche & Co. Aktiengesellschaft Acyl derivatives
GB8816519D0 (en) * 1987-07-23 1988-08-17 Ici Plc Antibiotic compounds
EP0366193A3 (de) * 1988-10-24 1992-01-08 Norwich Eaton Pharmaceuticals, Inc. Antimikrobielle Quinolonyllactame
DE4234078A1 (de) * 1992-10-09 1994-04-14 Bayer Ag Chinoloncarbonsäuren

Also Published As

Publication number Publication date
WO1995023153A1 (en) 1995-08-31
AU7706394A (en) 1995-09-11
EP0746561B1 (de) 1999-04-28
CO4340690A1 (es) 1996-07-30
DE69418218D1 (de) 1999-06-02
EP0746561A1 (de) 1996-12-11
ES2132430T3 (es) 1999-08-16
US5728691A (en) 1998-03-17
DE69418218T2 (de) 1999-11-04

Similar Documents

Publication Publication Date Title
IL112111A (en) Peptides having growth hormone releasing properties and pharmaceutical compositions containing them
BG101209A (bg) Хиполипидемични 1,4-бензотиазепин-1,1-диоксиди
BG101118A (en) Therapeutical compounds
NZ284846A (en) 1-substituted-pyrazolo[3,4-b]pyridin-5-carboxylic acid derivatives, preparation, use, intermediates and pharmaceutical compositions thereof
BR9713363A (pt) Epotilonas c, d, e e f, preparação e composições
IL112572A0 (en) Dexanabinol derivatives and their use as nmda blocking pharmaceutical compositions
BR9611400A (pt) "agentes antimicobiano de benzoxazina".
ES8500932A1 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
ATE179422T1 (de) Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
PT86186A (en) Process for the preparation of benzimidazol derivatives and of pharmaceutical compositions containing the same
BG103947A (en) Derivatives of 9-oxymerythromycin
BG103219A (bg) Бензамидинови производни и използването им като лекарствени средства с ltb4-антагонистично действие
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
PL329027A1 (en) Derivatives of benzopyrane exhibiting antagonistic activity in respect to leucotriene
SE9401540D0 (sv) Munhygienkomposition
MX9403088A (es) Composiciones farmaceuticas que contienen deriva- dos de indol y metodos de uso.
WO1996022305A3 (en) Modified peptides
AU6122994A (en) Hiv protease inhibitors and their preparation
NZ510153A (en) Tan-1057 derivatives with reduced toxicity and their use in medicaments for treating bacterial infections in humans and mammals
AU1275401A (en) Fibrous-liponutritional complexes and compositions containing them
CA2037779A1 (en) Antibiotic ge 2270 factors b1, b2, c1, c2, d1, d2, e and t
DE60035133D1 (de) Pharmazeutische zusammensetzungen mit wundheilender und anti-komplementärer wirkung die ein dextranderivat enthalten
ITMI922742A0 (it) Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
TR200003451T2 (tr) Pirimidin-Aminometil-Piridin Türevleri, Hazırlanmaları ve helikobakter bakterinin kontrolünde kullanımları

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties